Early release pattern of S100 protein as a marker of brain damage after warm cardiopulmonary bypass

M Shaaban Ali1, M Harmer, R S Vaughan

  • 1Department of Anaesthetics and Intensive Care Medicine, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK.

Anaesthesia
|August 18, 2000
PubMed

Insights

Warm cardiopulmonary bypass with warm blood cardioplegia may cause early brain S100 protein release, an indicator of brain damage. Peak S100 levels correlate with patient age, suggesting age is a factor in monitoring brain injury after surgery.

Area of Science:

  • Cardiovascular Surgery
  • Neuroscience
  • Biomarkers

Background:

  • The neurological effects of warm cardiopulmonary bypass (CPB) and warm blood cardioplegia are debated.
  • S100 protein is an established early marker for brain damage, detected previously after cold CPB.

Purpose of the Study:

  • To investigate S100 protein concentrations in patients undergoing coronary artery bypass surgery (CABG) with warm CPB and warm blood cardioplegia.
  • To determine the relationship between S100 protein levels and patient age following this procedure.

Main Methods:

  • Studied 20 patients undergoing CABG.
  • Measured S100 protein levels before and immediately after warm CPB (34-37°C) with warm blood cardioplegia (37°C).
  • Analyzed the correlation between peak S100 levels and patient age.

Main Results:

  • Peak S100 protein levels were observed immediately after warm CPB, followed by a progressive decrease over 4.5 hours.
  • A significant positive correlation was found between peak S100 protein concentration and patient age (y = -3.2 + 0.08x).

Conclusions:

  • Warm CPB and warm blood cardioplegia are associated with an early release of S100 protein.
  • Patient age is a critical factor influencing S100 protein levels post-CPB and should be considered in future research and clinical assessments.